CUTANEOUS INVOLVEMENT IN MULTIPLE MYELOMA IN THE ERA OF PROTEASOME INHIBITORS: HAS THE DISMAL PROGNOSIS CHANGED?

Autor: Piazera, FZ, Costa, AR, Lima, GR, Maldonado, JVO, Bitencourte, HM, Vasconcelos, RS
Zdroj: In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S264-S264
Databáze: ScienceDirect